L. de Rossi

Phase I Study of the Angiogenesis Inhibitor BIBF 1120 in Patients with Advanced Solid Tumors

K. Mross, Martin Štefanič, Daniela Gmehling et al. · Clinical Cancer Research · 2009 · 169 citations

Medicine, Oncology, Pharmacology +16

Nevirapine versus Atazanavir/Ritonavir, Each Combined with Tenofovir Disoproxil Fumarate/Emtricitabine, in Antiretroviral-Naive HIV-1 Patients: The Arten Trial

Keikawus Arastéh, Horacio Migrone, Thomas A. Lutz et al. · Antiviral Therapy · 2010 · 109 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Activated protein C inhibits the release of macrophage inflammatory protein-1-alpha from THP-1 cells and from human monocytes

Martina Brueckmann, Ursula Hoffmann, L. de Rossi et al. · Cytokine · 2004 · 44 citations

Life Sciences, Cell Biology, Immunology +13

Lipid profiles for nevirapine vs. atazanavir/ritonavir, both combined with tenofovir disoproxil fumarate and emtricitabine over 48 weeks, in treatment-naïve HIV-1-infected patients (the ARTEN study)

Daniel Podzamczer, Jaime Andrade‐Villanueva, Bonaventura Clotet et al. · HIV Medicine · 2011 · 37 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Intraoperative Management of Severe Pulmonary Hypertension during Cardiac Surgery with Inhaled Iloprost

Steffen Rex, Thomas Büsch, Manfred Vettelschoss et al. · Anesthesiology · 2003 · 33 citations · Full text

Medicine, Perioperative Medicine, Surgery +11